Absence of CD47 in the tumor microenvironment modulates tumor metabolism and immunosuppressive signatures limiting breast cancer progression.
E. R. Stirling, Y.-T. Tsai, S. M. Bronson, A. J. Wilson, B. Westwood, A. Thomas, P. L. Triozzi, C. M. Furdui, G. J. Lesser, K. L. Cook, D. R. Soto-Pantoja
This paper shows that CD47 absence in tumors reduces tumor burden and enhances immune response by altering metabolism and immunosuppressive signatures in breast cancer.
bioRxiv · Jul 12, 2023 · PreprintCancer Biology